IP Verse

Methods Of Purifying Polypeptides - EP3299380

The patent EP3299380 was granted to F Hoffmann LA Roche on Aug 28, 2024. The application was originally filed on May 25, 2011 under application number EP17167800A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3299380

F HOFFMANN LA ROCHE
Application Number
EP17167800A
Filing Date
May 25, 2011
Status
Granted And Under Opposition
Jul 26, 2024
Publication Date
Aug 28, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MESTERMay 28, 2025GRUNDADMISSIBLE
ZWICKER SCHNAPPAUF & PARTNERMay 27, 2025ZWICKERADMISSIBLE

Patent Citations (51) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0003089
DESCRIPTIONEP0073657
DESCRIPTIONEP0402226
DESCRIPTIONEP0404097
DESCRIPTIONUS2006067930
DESCRIPTIONUS4399216
DESCRIPTIONUS4419446
DESCRIPTIONUS4601978
DESCRIPTIONUS4676980
DESCRIPTIONUS4704362
DESCRIPTIONUS4816567
DESCRIPTIONUS4965199
DESCRIPTIONUS5208020
DESCRIPTIONUS5229275
DESCRIPTIONUS5500362
DESCRIPTIONUS5534615
DESCRIPTIONUS5545807
DESCRIPTIONUS5565332
DESCRIPTIONUS5567610
DESCRIPTIONUS5571894
DESCRIPTIONUS5573905
DESCRIPTIONUS5587458
DESCRIPTIONUS5589369
DESCRIPTIONUS5591669
DESCRIPTIONUS5641870
DESCRIPTIONUS5693780
DESCRIPTIONUS5712374
DESCRIPTIONUS5731168
DESCRIPTIONUS5736137
DESCRIPTIONUS5821337
DESCRIPTIONUS5840523
DESCRIPTIONUS6703018
DESCRIPTIONUS7169901
DESCRIPTIONUS7521541
DESCRIPTIONWO8905859
DESCRIPTIONWO9013646
DESCRIPTIONWO9100360
DESCRIPTIONWO9220373
DESCRIPTIONWO9308829
DESCRIPTIONWO9311161
DESCRIPTIONWO9316185
DESCRIPTIONWO9404690
DESCRIPTIONWO9411026
OPPOSITIONWO2006099308
OPPOSITIONWO2008091740
OPPOSITIONWO2008145351
OPPOSITIONWO2009058812
OPPOSITIONWO2009138484
OPPOSITIONWO2010019148
SEARCHUS5545328
SEARCHWO9727757

Non-Patent Literature (NPL) Citations (85) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- A. L. LEHNINGER, Biochemistry, 2nd ed., Worth Publishers, (19750000), pages 73 - 75
DESCRIPTION- BRENNAN et al., Science, (19850000), vol. 229, page 81
DESCRIPTION- BRODEUR et al., Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., (19870000), pages 51 - 63
DESCRIPTION- BRUGGERMANN et al., Year in Immuno., (19930000), vol. 7, page 33
DESCRIPTION- CAPEL et al., Immunomethods, (19940000), vol. 4, pages 25 - 34
DESCRIPTION- CARON et al., J. Exp Med., (19920000), vol. 176, pages 1191 - 1195
DESCRIPTION- CARTER et al., BiolTechnology, (19920000), vol. 10, pages 163 - 167
DESCRIPTION- CARTER et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, page 4285
DESCRIPTION- CHOTHIA et al., J. Mol. Biol., (19870000), vol. 196, page 901
DESCRIPTION- CHOTHIA; LESK, J. Mol. Biol., (19870000), vol. 196, pages 901 - 917
DESCRIPTION- CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628
DESCRIPTION- CLYNES et al., PNAS (USA), (19980000), vol. 95, pages 652 - 656
DESCRIPTION- CUNNINGHAM; WELLS, Science, (19890000), vol. 244, pages 1081 - 1085
DESCRIPTION- DAERON, Annu. Rev. Immunol., (19970000), vol. 15, pages 203 - 234
DESCRIPTION- DE HAAS et al., J. Lab. Clin. Med., (19950000), vol. 126, pages 330 - 41
DESCRIPTION- FLEER et al., BiolTechnology, (19910000), vol. 9, pages 968 - 975
DESCRIPTION- GAZZANO-SANTORO et al., J. Immunol. Methods, (19960000), vol. 202, page 163
DESCRIPTION- GODING, Monoclonal Antibodies: Principles and Practice, Academic Press, (19860000), pages 59 - 103
DESCRIPTION- GRAHAM; VAN DER EB, Virology, (19780000), vol. 52, pages 456 - 457
DESCRIPTION- GRIFFITH et al., EMBO J., (19930000), vol. 12, pages 725 - 734
DESCRIPTION- GRUBER et al., J. Immunol., (19940000), vol. 152, page 5368
DESCRIPTION- GUYER et al., J. Immunol., (19760000), vol. 117, page 587
DESCRIPTION- HENDY et al., J. Immunol. Methods, (19990000), vol. 231, pages 137 - 146
DESCRIPTION- HOLLINGER et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448
DESCRIPTION- HSIAO et al., Proc. Natl. Acad. Sci. (USA), (19790000), vol. 76, page 3829
DESCRIPTION- JAKOBOVITS et al., Nature, (19930000), vol. 362, pages 255 - 258
DESCRIPTION- JAKOBOVITS et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, page 2551
DESCRIPTION- JOHNSON, KEVIN S.; CHISWELL, DAVID J., Current Opinion in Structural Biology, (19930000), vol. 3, pages 564 - 571
DESCRIPTION- JONES et al., Nature, (19860000), vol. 321, pages 522 - 525
DESCRIPTION- JONES, Genetics, (19770000), vol. 85, page 12
DESCRIPTION- KEOWN et al., Methods in Enzymology, (19900000), vol. 185, pages 527 - 537
DESCRIPTION- KIM et al., J. Immunol., (19940000), vol. 24, page 249
DESCRIPTION- KOHLER et al., Nature, (19750000), vol. 256, page 495
DESCRIPTION- KOSTELNY et al., J. Immunol., (19920000), vol. 148, no. 5, pages 1547 - 1553
DESCRIPTION- KOZBOR, J. Immunol., (19840000), vol. 133, page 3001
DESCRIPTION- LARRICK et al., Res. Immunol., (19980000), vol. 149, pages 603 - 608
DESCRIPTION- MANSOUR et al., Nature, (19880000), vol. 336, pages 348 - 352
DESCRIPTION- MARKS et al., BiolTechnology, (19920000), vol. 10, pages 779 - 783
DESCRIPTION- MARKS et al., J. Mol. Biol., (19910000), vol. 222, pages 581 - 597
DESCRIPTION- MCCAFFERTY et al., Nature, (19900000), vol. 348, pages 552 - 553
DESCRIPTION- MCCAFFERTY et al., Nature, (19900000), vol. 348, pages 552 - 554
DESCRIPTION- MERRIFIELD, J. Am. Chem. Soc., (19630000), vol. 85, pages 2149 - 2154
DESCRIPTION- MILLSTEIN et al., Nature, (19830000), vol. 305, pages 537 - 539
DESCRIPTION- MOORE et al., Cytotechnology, (19950000), vol. 17, pages 1 - 11
DESCRIPTION- MORIMOTO et al., Journal of Biochemical and Biophysical Methods, (19920000), vol. 24, pages 107 - 117
DESCRIPTION- MORRISON et al., Proc. Natl Acad. Sci. USA, (19840000), vol. 81, page 6851
DESCRIPTION- MORRISON et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6851 - 6855
DESCRIPTION- MUNSON et al., Anal. Biochem., (19800000), vol. 107, page 220
DESCRIPTION- PLUCKTHUN, Immunol. Revs., (19920000), vol. 130, pages 151 - 188
DESCRIPTION- PLUCKTHUN, The Pharmacology of Monoclonal Antibodies, Springer-Verlag, (19940000), vol. 113, pages 269 - 315
DESCRIPTION- PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596
DESCRIPTION- PRESTA et al., J. Immunol., (19930000), vol. 151, page 2623
DESCRIPTION- RAVETCH; KINET, Annu. Rev. Immunol, (19910000), vol. 9, pages 457 - 92
DESCRIPTION- REYES et al., Nature, (19820000), vol. 297, pages 598 - 601
DESCRIPTION- RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327
DESCRIPTION- RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 329
DESCRIPTION- SHAW et al., Gene, (19830000), vol. 23, page 315
DESCRIPTION- SHOPES, B. J., Immunol., (19920000), vol. 148, pages 2918 - 2922
DESCRIPTION- SIMS et al., J. Immunol., (19930000), vol. 151, page 2296
DESCRIPTION- SKERRA et al., Curr. Opinion in Immunol., (19930000), vol. 5, pages 256 - 262
DESCRIPTION- STEVENSON et al., Anti-Cancer Drug Design, (19890000), vol. 3, pages 219 - 230
DESCRIPTION- STINCHCOMB et al., Nature, (19790000), vol. 282, page 39
DESCRIPTION- SURESH et al., Methods in Enzymology, (19860000), vol. 121, page 210
DESCRIPTION- TRAUNECKER et al., EMBO J., (19910000), vol. 10, pages 3655 - 3659
DESCRIPTION- TUTT et al., J. Immunol., (19910000), vol. 147, page 60
DESCRIPTION- VAN DEN BERG, BiolTechnology, (19900000), vol. 8, page 135
DESCRIPTION- VAN SOLINGEN et al., J. Bact., (19770000), vol. 130, page 946
DESCRIPTION- VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536
DESCRIPTION- VITETTA et al., Science, (19870000), vol. 238, page 1098
DESCRIPTION- WATERHOUSE et al., Nuc. Acids. Res., (19930000), vol. 21, pages 2265 - 2266
DESCRIPTION- WOLFF et al., Cancer Research, (19930000), vol. 53, pages 2560 - 2565
DESCRIPTION- YANIV, Nature, (19820000), vol. 297, pages 17 - 18
OPPOSITION- Anonymous, "POROS® XS Strong Cation Exchange Resin - Instructions", AB applied biosystems, (20100901), XP093283681
OPPOSITION- D9 - Product sheet of Mustang® S membrane (pgs. 297-432), date?
OPPOSITION- Ge Healthcare, "CM Sepharose Fast Flow, DEAE Sepharose Fast Flow, Q Sepharose Fast Flow, SP Sepharose Fast Flow", Instructions Manual 71-5009-64 AE, (20071001), pages 1 - 24, XP093198781
OPPOSITION- P. Qian, J.J. Schoenau, N. Ziadi, "Chapter13: Ion Supply Rates Using Ion-Exchange Resins", P. Qian, J.J. Schoenau, N. Ziadi, M.R. Carter, E.G. Gregorich, Soil Sampling and Methods of Analysis, 2nd Edition, Canadian Society of Soil Science, (20080101), pages 135 - 140, ISBN 978-0-8493-3586-0, XP009561878
OPPOSITION- Y. Yigzaw et al., "Ion Exchange Chromatography of Proteins and Clearance of Aggregates", Current Pharmaceutical Biotechnology, (2009), vol. 10, page 4, XP009149949
OPPOSITION- Sherrie Curtis; Kitty Lee; Gregory S. Blank; Kurt Brorson; Yuan Xu, "Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow‐through mode", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20030818), vol. 84, no. 2, doi:10.1002/bit.10746, ISSN 0006-3592, pages 179 - 186, XP071152957
OPPOSITION- KELLEY BRIAN D ET AL, "Weak partitioning chromatography for anion exchange purification of monoclonal antibodies.", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20081015), vol. 101, no. 3, doi:10.1002/it.21923, ISSN 0006-3592, pages 553 - 566, XP002545519
OPPOSITION- Londo, T. Lynch, P. Kehoe, T. Meys, M. Gordon, N., "Accelerated recombinant protein purification process development - Automated, robotics-based integration of chromatographic purification and analysis", Journal of Chromatography A, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (19980306), vol. 798, no. 1-2, doi:10.1016/S0021-9673(97)01205-3, ISSN 0021-9673, pages 73 - 82, XP004112342
OPPOSITION- Arick Brown, Jerome Bill, Timothy Tully, Asha Radhamohan, Chris Dowd, "Overloading ion-exchange membranes as a purification step for monoclonal antibodies", Biotechnology and Applied Biochemistry, (20100519), vol. 56, no. 2, doi:10.1042/BA20090369, ISSN 08854513, pages 59 - 70, XP055137278
OPPOSITION- FAHRNER R L, ET AL, "Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes", BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, INTERCEPT LTD., ANDOVER, GB, GB , (20010701), vol. 18, no. 12, doi:10.1080/02648725.2001.10648017, ISSN 0264-8725, pages I - 301-327, XP003035628
OPPOSITION- Hui F. Liu, Beth McCooey, Tiago Duarte, Deanna E. Myers, Terry Hudson, Ashraf Amanullah, Robert van Reis, Brian D. Kelley, "Exploration of overloaded cation exchange chromatography for monoclonal antibody purification", Journal of Chromatography A, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20110928), vol. 1218, no. 39, doi:http://dx.doi.org/10.1016/j.chroma.2011.08.008, ISSN 0021-9673, pages 6943 - 6952, XP002668917
SEARCH- Pete Gagnon, "Purification of Monoclonal Antibodies by Mixed-Mode Chromatography", Process Scale Purification of Antibodies, Hoboken, NJ, USA, John Wiley & Sons, Inc., (20090123), pages 125 - 143, doi:10.1002/9780470444894.ch6, ISBN 978-0-47-020962-2, XP055137310 [Y] 1-31 * the whole document *
SEARCH- ARICK BROWN ET AL, "Overloading ion-exchange membranes as a purification step for monoclonal antibodies", BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, (20100519), vol. 56, no. 2, doi:10.1042/BA20090369, ISSN 0885-4513, pages 59 - 70, XP055137278 [Y] 1-31 * the whole document *

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents